Symbols

FEED

ENvue Medical·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About FEED

Envue Medical, Inc.

Industry

Healthcare Equipment and Supplies

Established Date

10/20/2003

Listing Date

11/02/2017

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.nanovibronix.com

Security Type

Common stock

Office address

969 Pruitt Ave, Tyler, Texas 77569

Business

Introduction

ENvue Medical, Inc., was incorporated in Delaware on October 20, 2003. ENvue Medical operates through two wholly owned subsidiaries: NanoVibronix Ltd., located in Israel, and ENvue Medical Holdings LLC, located in Delaware. Nano OpCo focuses on the development of non-invasive biological reaction activation devices that can be used to prevent biofilm formation, relieve pain and promote wound healing, and can be used at home without the assistance of medical professionals. ENvue is a medical device company engaged in the research and development, production, marketing and sales of medical devices in the field of enteral nutrition.

Company Financials

EPS

FEED has released its 2025 Q2 earnings. EPS was reported at -1.03, versus the expected 0, missing expectations. The chart below visualizes how FEED has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

FEED has released its 2025 Q3 earnings report, with revenue of 722.00K, reflecting a YoY change of 92.02%, and net profit of 510.00K, showing a YoY change of 151.10%. The Sankey diagram below clearly presents FEED's revenue sources and cost distribution.